Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective Randomised Non-inferiority Nordic Frostbite Treatment Study
2018-000712-15Phase 4Active
- Sponsor
- Andrew Lindford
- Start
- Sep 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in frostbite comparing Ilomedin arm with Actilyse arm (2 arms). Primary endpoint: Initial survival or non-survival of distal extremity at risk. Started Sep 2018; status: active.
02
Drugs
iloprosttissue-plasminogen activator
03
Conditions
frostbite
Beyond the preview
Go deeper on 2018-000712-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000712-15.